Latest Blogs

Feb 14, 2019
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Feb 14, 2019
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
Feb 11, 2019
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
Subscribe to this column

International Perspectives

International Perspectives provides an interactive platform for international leaders in their respective fields to share perspectives on oncology topics. International Perspectives contributors are invited to post by invitation from ASCO’s volunteer leadership and key staff.

Feb 02, 2015
Owing to insufficient public and private investment in chronic disease prevention and control, millions of sub-Saharan Africans present with late stage, life-threatening diseases -- including cancer. Because of poor health systems and symptom control infrastructure, and limited numbers of...
Feb 02, 2015
By Monica Malik MD, DNB. It is estimated that almost 50% of all cancers are related to unhealthy choices like tobacco, alcohol, physical inactivity, unhealthy eating habits, unsafe sex and other modifiable environmental factors. Obesity is already on its way to overtake tobacco as the leading cause...
Feb 02, 2015
By Ian N. Olver, MD, PhD, FRACP. One-third of cancer deaths could be prevented by lifestyle choices alone. If there was a drug that claimed that success, it would be front page news. Changing behavior doesn’t seem dramatic, yet can be very difficult to achieve. The three areas in which the most...
Feb 02, 2015
By Sana Al Sukhun, MD, MSc, President of Jordan Oncology Society. Early detection has become the motto of public health campaigns all over the world. Not only does it reduce the burden of disease by reducing morbidity (complications of both disease and treatment), but also by reducing associated...
Feb 02, 2015
By Paul Ruff, MD, University of Witwatersrand, Johannesburg, South Africa. Since the turn of the century, we have seen a paradigm shift in the way we treat cancer, with the advent of targeted therapies, especially monoclonal antibodies and small molecule kinase inhibitors. Indeed the development of...
Nov 18, 2014
Tanja Cufer, MD, PhDASCO International Clinical Trials Workshop (ICTW) Working Group Chair    Dr. Tanja Cufer presents at the International Clinical Trials 

Pages